{"SPADE_N_03156": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2006/0034820 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2006_0034820_A1", "Patent Type": "Patent Application", "Publication Date": "2006-2-16", "Family Info": "US7338936,US20070207963,US20090023893", "Patent Title": "Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis.", "Abstract": "The pharmaceutical composition and a method of treatment of infectious diseases, such as otitis media, paranasal sinusitis, labyrinthitis and meningitis are described. The composition comprises EP2E or homologues thereof."}], "Sequence Information": {"SPADE ID": "SPADE_N_03156", "Peptide Name": "Human beta-defensin 4 (hBD-4, BD-4; Beta-defensin 104; Human, mammals, animals)", "Source": "Homo sapiens (Human)", "Family": "Belongs to the beta-defensin family", "Gene": "DEFB104A", "Sequence": "EFELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRKWDESLLNRTKP", "Sequence Length": 50, "UniProt Entry": ["http://www.uniprot.org/uniprot/Q8WTQ1", "http://www.uniprot.org/uniprot/Q496I2", "http://www.uniprot.org/uniprot/Q496I3", "http://www.uniprot.org/uniprot/Q496I4"], "Protein Existence": "Transcript level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "Gram-positive bacterium:Staphylococcus carnosus TM300 (MIC=4.5 µg/ml);Gram-negative bacteria:Escherichia coli BL21 (MIC>100 µg/ml), Pseudomonas aeruginosa (MIC=4.1 µg/ml).Yeast:Saccharomyces cerevisiae ATCC9763 (MIC>100 µg/ml).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "Not found", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C254H410N82O74S6", "Mass": 5988.87, "PI": 9.27, "Net Charge": 6, "Hydrophobicity": -1.01, "Half Life": "Mammalian:1 hourYeast:30 minE.coli:>10 hour", "Function": "Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103.", "Tissue specificity": "High expression in the testis. Gastric antrum exhibited relatively high levels. A lower expression is observed in uterus and neutrophils thyroid gland, lung, and kidney. No detectable expression in other tissues tested.", "Induction": "Antimicrobial activity is decreased when the sodium chloride concentration is increased.", "PTM": "Contains three disulfide bonds (By similarity).", "Literature": [{"Title": "Human beta-defensin 4 a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity.", "Pubmed ID": "11481241", "Reference": "FASEB J. 2001 Aug;15(10)1819-1821.", "Author": "García JR, Krause A, Schulz S, Rodríguez-Jiménez FJ, Klüver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R, Forssmann WG.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=11481241"}, {"Title": "Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.", "Pubmed ID": "R2005J0403", "Author": "Zhang G.,Blecha F.,Sang Y.,Cai Y.,Patil A.A."}, {"Title": "The complexity of selection at the major primate beta-defensin locus.", "Pubmed ID": "R2005J1377", "Author": "Eastwood H.,Kilanowski F.M.,Gautier P.,Maxwell A.,Semple C.A.M."}], "Frequent Amino Acids": "RCE", "Absent Amino Acids": "HMOUV", "Basic Residues": 12, "Acidic Residues": 6, "Hydrophobic Residues": 15, "Polar Residues": 31, "Positive Residues": 12, "Negative Residues": 6, "Similar Sequences": [{"SPADE_ID": "SPADE_N_08024", "Similarity": 1.0, "Sequence": "MQRLVLLLAVSLLLYQDLPVRSEFELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRKWDESLLNRTKP"}, {"SPADE_ID": "SPADE_N_11938", "Similarity": 1.0, "Sequence": "EFELDRIGYGTARCRKKRSQEYRIGRPNTYACLRK"}, {"SPADE_ID": "SPADE_N_11939", "Similarity": 1.0, "Sequence": "EFELDRICGYGTARCRKKRSQEYRIGRPNTYACCLRK"}]}}}